BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 27845164)

  • 1. Enhanced CRISPR/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA.
    Liang X; Potter J; Kumar S; Ravinder N; Chesnut JD
    J Biotechnol; 2017 Jan; 241():136-146. PubMed ID: 27845164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome editing with the donor plasmid equipped with synthetic crRNA-target sequence.
    Ishibashi R; Abe K; Ido N; Kitano S; Miyachi H; Toyoshima F
    Sci Rep; 2020 Aug; 10(1):14120. PubMed ID: 32839482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
    Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
    Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Precise Genome Editing Using Donor DNA/gRNA Hybrid Duplex Generated by Complementary Bases.
    Aiba W; Amai T; Ueda M; Kuroda K
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creation of zebrafish knock-in reporter lines in the nefma gene by Cas9-mediated homologous recombination.
    Eschstruth A; Schneider-Maunoury S; Giudicelli F
    Genesis; 2020 Jan; 58(1):e23340. PubMed ID: 31571409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A novel CRISPR/Cas9-hLacI donor adapting system for dsDNA-templated gene editing].
    Ma B; Cui J; Qian H; Zhang X; Yang S; Zhang Q; Han Y; Zhang Z; Wang J; Xu K
    Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):4204-4218. PubMed ID: 37877400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 Technology in Translational Biomedicine.
    Leonova EI; Gainetdinov RR
    Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baculovirus-based genome editing in primary cells.
    Mansouri M; Ehsaei Z; Taylor V; Berger P
    Plasmid; 2017 Mar; 90():5-9. PubMed ID: 28119062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing endogenous repair mechanisms for targeted gene knock-in of bovine embryos.
    Owen JR; Hennig SL; McNabb BR; Lin JC; Young AE; Murray JD; Ross PJ; Van Eenennaam AL
    Sci Rep; 2020 Sep; 10(1):16031. PubMed ID: 32994506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery.
    Lin S; Staahl BT; Alla RK; Doudna JA
    Elife; 2014 Dec; 3():e04766. PubMed ID: 25497837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
    He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
    Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage.
    Zhang JP; Li XL; Li GH; Chen W; Arakaki C; Botimer GD; Baylink D; Zhang L; Wen W; Fu YW; Xu J; Chun N; Yuan W; Cheng T; Zhang XB
    Genome Biol; 2017 Feb; 18(1):35. PubMed ID: 28219395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Genome Editing with CRISPR-Cas9.
    Rahman S; Ikram AR; Azeem F; Tahir Ul Qamar M; Shaheen T; Mehboob-Ur-Rahman
    Methods Mol Biol; 2024; 2788():355-372. PubMed ID: 38656525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
    Bloomer H; Smith RH; Hakami W; Larochelle A
    Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient SSA-mediated precise genome editing using CRISPR/Cas9.
    Li X; Bai Y; Cheng X; Kalds PGT; Sun B; Wu Y; Lv H; Xu K; Zhang Z
    FEBS J; 2018 Sep; 285(18):3362-3375. PubMed ID: 30085411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
    Liu GG; Li S; Wei YD; Zhang YX; Ding QR
    Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.